Ariad Pharmaceuticals, Inc. News, Ariad Pharmaceuticals, Inc. Quote, ARIA Quote

Ariad Pharmaceuticals, Inc. (NQ:ARIA) Delayed: 17.79 -0.02 (0.11%)
Previous Close	$17.81	52 Week High	$25.40
Open	$17.85	52 Week Low	$15.35
Day High	$17.99	P/E	N/A
Day Low	$17.43	EPS	$-1.35
Volume	218,969

Friends, Peers and Foes (?): ISIS, GOL, AAPL, PAY, QCOM (more...)

ALERTS | RSS

Jun 18, 2013 02:14 PM ARIAD Honored with Gold Stevie® Awards as Pharmaceutical Company of the Year at 2013 American Business Awardssm
Jun 13, 2013 07:35 AM ARIAD Announces Webcast of Its Annual Shareholders Meeting
Jun 11, 2013 10:30 AM Ash Stevens to Manufacture Ponatinib API
Jun 11, 2013 07:36 AM Ariad Pharma (ARIA) Commences Iclusig Phase 2
Jun 11, 2013 07:35 AM ARIAD Announces Initiation of Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors
Jun 4, 2013 04:31 PM Form 8-K ARIAD PHARMACEUTICALS For: Jun 01
Jun 4, 2013 07:30 AM ARIAD to Present at Upcoming Investor Conferences
Jun 3, 2013 09:13 AM Jefferies Maintains Bullish Stance on ARIAD (ARIA) After ASCO
Jun 2, 2013 09:00 AM ARIAD Presents Updated Phase 1 Data on AP26113 in Patients with Non-Small Cell Lung Cancer
Jun 2, 2013 09:00 AM ARIAD Announces Long-Term Durability-of-Response Data on Ponatinib from Ongoing Phase 1 Study

Entities mentioned with ARIA

View All Entities